Biblio

Export 1356 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2020
S. X. Naughton, Raval, U., and Pasinetti, G. M., “Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.”, J Alzheimers Dis, vol. 76, no. 1, pp. 21-25, 2020.
D. Wong, Atiya, S., Fogarty, J., Montero-Odasso, M., Pasternak, S. H., Brymer, C., Borrie, M. J., and Bartha, R., “Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1385-1405, 2020.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L., “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L., “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L., “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L., “Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
C. Liguori, Spanetta, M., Izzi, F., Franchini, F., Nuccetelli, M., Sancesario, G. Maria, Di Santo, S., Bernardini, S., Mercuri, N. Biagio, and Placidi, F., “Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.”, J Alzheimers Dis, vol. 74, no. 2, pp. 501-508, 2020.
B. - S. Rauchmann, Sadlon, A., and Perneczky, R., “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A., “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
2019
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
K. E. Osborn, Alverio, J. M., Dumitrescu, L., Pechman, K. R., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., and Jefferson, A. L., “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
R. Peters, Ee, N., Peters, J., Booth, A., Mudway, I., and Anstey, K. J., “Air Pollution and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 70, no. s1, pp. S145-S163, 2019.
R. Peters, Ee, N., Peters, J., Booth, A., Mudway, I., and Anstey, K. J., “Air Pollution and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 70, no. s1, pp. S145-S163, 2019.
H. - B. Kim, Park, B., and Shim, J. - Y., “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
L. Letra, Matafome, P., Rodrigues, T., Duro, D., Lemos, R., Baldeiras, I., Patrício, M., Castelo-Branco, M., Caetano, G., Seiça, R., and Santana, I., “Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 67, no. 2, pp. 725-735, 2019.

Pages